JMP Securities Starts Gritstone bio (GRTS) at Market Outperform, 'NT High-Risk/Reward Cancer Vaccine Catalyst'
Tweet Send to a Friend
(Updated - February 28, 2024 3:09 AM EST)
JMP Securities analyst Roy Buchanan initiates coverage on Gritstone bio (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JMP Securities analyst Roy Buchanan initiates coverage on Gritstone bio (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
